Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion type Assertion NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_head.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion evidence source_evidence_literature NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion SIO_000772 22291441 NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion wasDerivedFrom befree-20150227 NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.
- NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion wasGeneratedBy ECO_0000203 NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.